Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00732537 · ClinicalTrials.gov registry record · Phase 4

Inhaled Nitric Oxide by Oxygen Hood in Neonates

A Phase 4 study of Respiratory Failure and Infant, sponsored by University of Alabama at Birmingham.

Completed
Registry status
Phase 4
Development phase
8
Enrollment target
1
Study location

NCT00732537 is a Phase 4 study of Respiratory Failure and Infant that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 8 participants, below the 4,524-participant average among 40 other Respiratory Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00732537, a Phase 4 study of Respiratory Failure and Infant, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
Phase 4
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

Inhaled nitric oxide (iNO) improves oxygenation in term infants with respiratory failure. However, iNO has been primarily used in infants receiving mechanical ventilation. This study is a pilot study to determine if iNO given into an oxygen hood is effective in improving oxygenation in term and near-term infants who have poor oxygenation but who are not yet mechanically ventilated.

Interventions

  • DRUG inhaled Nitric Oxide
  • DRUG Oxygen (>90% by hood) - standard therapy

Study Locations (1)

Alabama

  • Regional Neonatal ICU, University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 1999-03
Est. Completion 2005-06
Phase Phase 4

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT00732537

The ClinicalTrials.gov registry entry for NCT00732537 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,524-participant average among 40 other Respiratory Failure trials with a reported enrollment target (100% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which inhaled Nitric Oxide is the first listed.

NCT00732537 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT00732537 about?

NCT00732537 is a clinical study titled "Inhaled Nitric Oxide by Oxygen Hood in Neonates". Inhaled nitric oxide (iNO) improves oxygenation in term infants with respiratory failure. However, iNO has been primarily used in infants receiving mechanical ventilation. This study is a pilot study to determine if iNO given into an oxygen hood is effective in improving oxygenation in term and near...

What is the current status of trial NCT00732537?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 1999-03. Estimated completion is 2005-06.

What conditions does trial NCT00732537 study?

This clinical trial studies the following conditions: Respiratory Failure, Infant, Persistent Fetal Circulation.

What interventions are being tested in trial NCT00732537?

The interventions under investigation include: inhaled Nitric Oxide (DRUG), Oxygen (>90% by hood) - standard therapy (DRUG).

Who is sponsoring clinical trial NCT00732537?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00732537 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.